No biomarker	Multiple Myeloma	No biomarker	Multiple Myeloma	CCS1477 Sensitive: B - Late Trials CCS1477 Sensitive : B	CCS1477 Sensitive: B - Late Trials CCS1477 Sensitive : B
AR positive	Breast Cancer	AR positive	Breast Cancer	FT-6876 Sensitive: D – Preclinical FT-6876 Sensitive : D	FT-6876 Sensitive: D – Preclinical FT-6876 Sensitive : D
MYC expression	Multiple Myeloma	MYC expression	Multiple Myeloma	lenalidomide + CCS1477 Sensitive: D – Preclinical lenalidomide + CCS1477 Sensitive : D	lenalidomide + CCS1477 Sensitive: D – Preclinical lenalidomide + CCS1477 Sensitive : D
IRF4 expression	Multiple Myeloma	IRF4 expression	Multiple Myeloma	lenalidomide + CCS1477 Sensitive: D – Preclinical lenalidomide + CCS1477 Sensitive : D	lenalidomide + CCS1477 Sensitive: D – Preclinical lenalidomide + CCS1477 Sensitive : D
MYC expression	Acute Myelogenous Leukemia	MYC expression	Acute Myelogenous Leukemia	CCS1477 Sensitive: D – Preclinical CCS1477 Sensitive : D	CCS1477 Sensitive: D – Preclinical CCS1477 Sensitive : D

EP300 inhibitor

Associations(5)